logo

For the Inventor, By the Inventor

Yokohama, Japan

Takuo Nakano

USPTO Granted Patents = 19


Average Co-Inventor Count = 7.2

ph-index = 5

Forward Citations = 120(Granted Patents)


Location History:

  • Kanagawa, JP (1984 - 1985)
  • Yokohama, JP (1981 - 1994)

Company Filing History:

goldMedal8 out of 1,379 
 
Mitsui Toatsu Chemicals, Incorporated
 patents
silverMedal5 out of 7 
 
Mitsui Toatsu Kagaku Kabushiki Kaisha
 patents
bronzeMedal4 out of 1,008 
 
Mitsui Petrochemical Industries, Ltd.
 patents
4. 2 out of 10 
 
Mitsui Pharmaceuticals, Inc.
 patents
5. 1 out of 1 
 
Mitsui Toatsu Kagaki Kabushiki Kaisha
 patent
6. 1 out of 1 
 
Mitsui Toatsu Kaguku Kabushiki Kaisha
 patent
where one patent can have more than one assignee

Years Active: 1981-1994

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents
1. 5304555 - Pyrimidines and pharmaceutically acceptable salts thereof useful in (1994-04-19),
2. 5192799 - Coumaran group containing amine compounds and their acid addition salts (1993-03-09),
3. 4965263 - 6-acylaminophenyl-5-alkyl-4,5-dihydro-3(2H)-pyridazinone compounds (1990-10-23),
4. 4959368 - Therapeutic agent for neurological diseases (1990-09-25),
5. 4734418 - Quinazoline compounds and antihypertensives (1988-03-29),
6. 4639451 - Pyridazinone derivatives (1987-01-27),
7. 4532137 - 2-Thiazolamine derivatives, process for preparing same, and (1985-07-30),
8. 4523011 - Process for preparing 6-(substituted (1985-06-11),
9. 4521415 - 6-(Substituted phenyl)-4,5-dihydro-3(2H)-pyridazinone compounds (1985-06-04),
10. 4511574 - N-(4-Phenyl-2-thiazolyl)carbamate derivatives (1985-04-16),
11. 4501750 - Thiazole compounds, a process for preparing same and a pharmaceutical (1985-02-26),
12. 4490393 - Thiazolylurea derivatives, a process for preparing same and a (1984-12-25),
13. 4476128 - 2-Substituted thiazolyl-piperazine compounds, process for preparation (1984-10-09),
14. 4473577 - 2-Thiazolamine derivatives, process for preparing same, and (1984-09-25),
15. 4376119 - Benzothiazine derivative (1983-03-08),

Title: The Innovative Contributions of Takuo Nakano in Pharmaceuticals

Introduction

Takuo Nakano is a distinguished inventor based in Yokohama, Japan, recognized for his significant contributions to the pharmaceutical field. With an impressive portfolio of 19 patents, Nakano's innovations focus on developing compounds that target critical health issues, particularly in neurological and cardiac treatments.

Latest Patents

Among his latest inventions are novel pyrimidines and their pharmaceutically acceptable salts, designed to address neurological diseases affecting both the peripheral and central nervous systems of animals. This invention provides a promising avenue for treating such complex disorders. In addition, Nakano has developed coumaran group containing amine compounds and their acid addition salts. These compounds are formulated to aid in treating and preventing heart diseases such as arrhythmia, myocardial infarction, angina pectoris, heart failure, and psychoneurological conditions.

Career Highlights

Throughout his career, Nakano has been affiliated with notable companies including Mitsui Toatsu Chemicals, Incorporated, and Mitsui Toatsu Kagaku Kabushiki Kaisha. His work at these organizations has fostered an environment of innovation, allowing him to explore and develop his creative ideas in pharmaceutical formulations.

Collaborations

Collaboration plays a vital role in Nakano's success as an inventor. He has worked alongside esteemed colleagues such as Akira Awaya and Mikio Kumakura. Their teamwork has been instrumental in advancing their research efforts and amplifying the impact of their discoveries within the medical community.

Conclusion

Takuo Nakano's dedication to innovation in the pharmaceutical industry is evident through his extensive patent portfolio. His groundbreaking work in creating compounds for neurological and cardiac health not only showcases his inventive spirit but also offers hope for the treatment of challenging medical conditions. As he continues to push the boundaries of science and medicine, Nakano remains a significant figure in the world of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…